NCT06483243View on ClinicalTrials.gov

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic of CKD-501, D745, and D150 for Healthy Subjects in Fed State.

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

April 4, 2024

Primary Completion Date

April 29, 2024

Study Completion Date

May 17, 2024

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Test: CKD-383, Reference1: Duvie Tab. 0.5mg, Reference2: Jardiance tablets 25 mg, Reference3: GLUCOPHAGE XR TAB. 1000MG

At around 8 a.m., take Test drug or Reference drug 1,2,3(oral) with 200 mL of water at room temperature.

Trial Locations (1)

Unknown

Chung-Ang University Gwangmyeong Hospital, Gyeonggi-do

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY